Dexamethasone for cancer-related dyspnoea
- PMID: 36455574
- DOI: 10.1016/S1470-2045(22)00657-X
Dexamethasone for cancer-related dyspnoea
Conflict of interest statement
We declare no competing interests.
Comment in
-
Dexamethasone for cancer-related dyspnoea - Authors' reply.Lancet Oncol. 2022 Dec;23(12):e526. doi: 10.1016/S1470-2045(22)00699-4. Lancet Oncol. 2022. PMID: 36455575 No abstract available.
Comment on
-
Effect of dexamethasone on dyspnoea in patients with cancer (ABCD): a parallel-group, double-blind, randomised, controlled trial.Lancet Oncol. 2022 Oct;23(10):1321-1331. doi: 10.1016/S1470-2045(22)00508-3. Epub 2022 Sep 7. Lancet Oncol. 2022. PMID: 36087590 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical